Home
Octagon Capital Advisors reported a 3.6% stake in Dianthus Therapeutics DNTH · 1,946,667 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 3.6%
- Last report
- 6.1% · filed 25/11/14
- Shares held
- 1,946,667 sh
- Class
- Common Stock, $0.001 par value
- Holder
- Octagon Capital Advisors
- Event date
- 26/03/31
- Filed
- 26/05/14
3.6% stake · below 5%
- Stake
- 3.6%
- Last report
- 6.1%
- Since last report
- −2.5pp
Dianthus Therapeutics trades, last 26 weeks
What else happened in Dianthus Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Octagon Capital Advisors's other 5% stake reports
- Octagon Capital Advisors
5% stakeContext Therapeutics
5% stakeContext Therapeutics
CNTX
3.3% stake
3,050,000 sh
3.3% stake
Filed 07/31
- Octagon Capital Advisors
5% stakeContext Therapeutics
5% stakeContext Therapeutics
CNTX
5.7% stake
5,250,000 sh
5.7% stake
Filed 05/14
- Octagon Capital Advisors
5% stakeCorbus Pharmaceuticals Holdings
5% stakeCorbus Pharmaceuticals Holdings
CRBP
0% stake
0 sh
0% stake
Filed 05/14
- Octagon Capital Advisors
5% stakeGossamer Bio
5% stakeGossamer Bio
GOSS
3.8% stake
8,976,054 sh
3.8% stake
Filed 05/14
- Octagon Capital Advisors
5% stakeGossamer Bio
5% stakeGossamer Bio
GOSS
6.5% stake
15,141,425 sh
6.5% stake
Filed 02/17
